Alessia Chiaro
Molecular modelling to tailor glicodendrimers as drug delivery systems for anticancer nucleoside analogues targeting haematological malignancies.
Rel. Marco Agostino Deriu, Umberto Morbiducci. Politecnico di Torino, Corso di laurea magistrale in Ingegneria Biomedica, 2019
|
Preview |
PDF (Tesi_di_laurea)
- Tesi
Licenza: Creative Commons Attribution Non-commercial No Derivatives. Download (4MB) | Preview |
Abstract
Nowadays the application of nanotechnology in the field of biomedicine is rapidly rising and nanotechnology-based chemotherapy is widely apply to treat many type of cancers, such as hematological malignancies. This family of cancers includes various malignant neoplasms that affect blood or lymph systems. The interest of our study is focused on the drugs used to treat leukemia, which is an acute or chronic disease characterized by an abnormal increase in the number of white blood cells in the tissues and often also in the blood. To treat leukemia, many type of treatments are suggested and the most used technique is chemotherapy.
Among the various drugs, the nucleotide analogues (NAs) are one of the most efficient antimetabolites used to treat leukemia
Relatori
Anno Accademico
Tipo di pubblicazione
Numero di pagine
Corso di laurea
Classe di laurea
Aziende collaboratrici
URI
![]() |
Modifica (riservato agli operatori) |
